ISRG Stock Risk & Deep Value Analysis

Intuitive Surgical Inc

Healthcare โ€ข Medical Instruments & Supplies

DVR Score

3.0

out of 10

Risk Trap

The Bottom Line on ISRG

We analyzed Intuitive Surgical Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran ISRG through our deep value framework โ€” analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Apr 20, 2026โ€ขRun Fresh Analysis โ†’โ€ข

Get notified when ISRG moves

Same alert types as Telegram โ€” presets or custom thresholds in your ๐Ÿ”” feed.

๐Ÿ“ˆISRG Performance Overview3yr weekly

๐Ÿ“Š

Unlock ISRG Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close ยท Quarterly revenue & EPS ยท DVR score history

ISRG Quality Rating

3.0
7.0
Growth
9.0
Profitability
9.0
Health
6.0
Capital allocation
5.0
Momentum

ISRG Stock Risk Analysis

Overall Risk

Moderate

Financial Risk

Low

Market Risk

Medium

About Intuitive Surgical Inc (ISRG)

Sector

Healthcare

Industry

Medical Instruments & Supplies

Market Cap Category

large

Market Cap

$166.65B

ISRG Deep Value Analysis

Intuitive Surgical (ISRG) continues to demonstrate strong operational performance, evidenced by its Q4 2025 revenue growth of 18.8% YoY and robust EPS beat. It maintains its undisputed leadership in robotic-assisted surgery, supported by a growing installed base of 11,423 da Vinci systems and impressive Ion system adoption. The company's formidable moat, built on IP, high switching costs, and extensive R&D, ensures durable future growth within its expanding market. However, the premise of achieving a 10x return ($1.66 trillion valuation) within 3-5 years for a company of its current $166.65 billion market cap remains extraordinarily improbable. While a premier long-term compounder, its established large-cap status fundamentally limits multi-bagger potential within the aggressive timeframe, a view consistent with previous assessments. Recent product recalls, cybersecurity reports, and tariff headwinds introduce minor operational risks, partially offset by solid financial execution, thus maintaining the low 10x potential score.

ISRG Research Sources

Research sources

No external source links for this analysis yet. Run a fresh analysis to capture SEC filings and financial news articles we used.

For educational context only. Not financial advice.

ISRG Red Flags & Warning Signs

  • โš 

    Q1 2026 earnings miss or weak forward guidance

  • โš 

    Increased competitive pressure from new market entrants or established medical device giants

  • โš 

    Further regulatory scrutiny or product safety issues (e.g., additional recalls)

  • โš 

    Escalation of tariff impacts on gross margins

Unlock ISRG Red Flags & Risk Warnings

Premium members see every risk event we found.

๐Ÿ“ˆ

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

๐Ÿ”ฅ New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

  • โœ“ Catalysts, bull case, moat & red flags
  • โœ“ Unlimited stock analyses + alerts
  • โœ“ Full database, search & portfolio (50 stocks)
Get Premium โ€” $47/yr

7-day money back ยท Cancel anytime

ISRG Financial Health Metrics

Market Cap

$166.65B

P/E Ratio

58.35

Profit Margin

28.38%

Beta (Volatility)

1.56

Earnings Per Share

$7.88

ISRG Competitive Moat Analysis

Moat Rating

Wide

Moat Trend

Stable

Moat Sources

3 Identified

Switching CostsIntangible Assets/IPEfficient Scale

ISRG's moat is highly durable due to the deep integration of its systems into surgical workflows, the substantial investment in training required for surgeons, and its extensive patent portfolio. Replacing or significantly competing with its installed base effectively requires monumental capital and time, making its leadership highly resilient.

ISRG Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

ISRG Catalysts & Growth Drivers

Near-Term (0-6 months)

  • โ€ขQ1 2026 Earnings report (expected April 21, 2026)
  • โ€ขResolution and clear communication regarding da Vinci Xi EndoWrist Suction Irrigator recall

Medium-Term (6-18 months)

  • โ€ขAccelerated adoption of da Vinci 5 and Ion systems post-launch phase
  • โ€ขExpansion into new surgical procedure indications and global markets, particularly in emerging economies

Long-Term (18+ months)

  • โ€ขContinued R&D leading to next-gen robotic platforms or significant AI integration
  • โ€ขDeepening of the 'razor-and-blade' model, enhancing recurring revenue streams

Catalysts & Growth Drivers

Sign up free to see growth catalysts

ISRG Bull Case: What Could Go Right

  • โœ“

    Acceleration in da Vinci system placements and procedure growth exceeding guidance.

  • โœ“

    Successful integration of new technologies (e.g., AI/ML) into surgical platforms.

  • โœ“

    Maintenance or expansion of gross and operating margins despite tariff headwinds.

Bull Case Analysis

Sign up free to see the bull case

๐Ÿ“Š Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

FAQ

What is the DVR Score for Intuitive Surgical Inc (ISRG)?

As of April 20, 2026, Intuitive Surgical Inc has a DVR Score of 3.0 out of 10, placing it in the "Risk Trap" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Intuitive Surgical Inc?

Intuitive Surgical Inc's market capitalization is approximately $166.6B. The company operates in the Healthcare sector within the Medical Instruments & Supplies industry.

What ticker symbol does Intuitive Surgical Inc use?

ISRG is the ticker symbol for Intuitive Surgical Inc. The company trades on the NMS.

What is the risk level for ISRG stock?

Our analysis rates Intuitive Surgical Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of ISRG?

Intuitive Surgical Inc currently has a price-to-earnings (P/E) ratio of 58.4. This is above the market average, suggesting the stock may be priced for high growth expectations.

Is Intuitive Surgical Inc's revenue growing?

Intuitive Surgical Inc has reported revenue growth of 20.5%. The company is showing strong top-line momentum.

Is ISRG stock profitable?

Intuitive Surgical Inc has a profit margin of 28.4%. This indicates strong profitability.

How often is the ISRG DVR analysis updated?

Our AI-powered analysis of Intuitive Surgical Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 20, 2026.

Important Disclaimer โ€“ Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.